59.20 USD
↗ 2.31 (4.06%)AT CLOSE (11:59 AM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
59.12
↘ 0.09 (0.14%)
POST MARKET (AS OF 06:47 PM EDT)
Post Market
AS OF 06:47 PM EDT
59.12
↘ 0.09 (0.14%)
Market: CLOSED
Shares of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) are trading at $59.20. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place KNSA at a fair price relative to peers.
Technical & fundamental data as of Jun 26, 2026.
Open?$57.42
High?$59.77
Low?$56.56
Prev. Close?$56.89
Volume?6.8M
Avg. Volume?776.7K
VWAP?$58.69
Rel. Volume?8.70x
Bid / Ask
Bid?$48.59 × 100
Ask?$102.74 × 100
Spread?$54.15
Midpoint?$75.66
Valuation & Ratios
Market Cap?4.6B
Shares Out?46.3M
Float?38.9M
Float %?84.2%
P/E Ratio?62.34
P/B Ratio?7.52
EPS?$0.95
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?87
Short Sent.?40
Piotroski F-Score?5/9Mixed
Altman Z-Score?13.62Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?7.57%Elevated
Short Interest?2.9M
Days to Cover?5.7
Free Float38.9M
Avg Daily Volume514.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.79Strong
Quick Ratio?3.33Strong
Cash Ratio?1.21Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score56/100
P/E?62.3PRICEY▾
Peers100
S&P8
P/B?7.52FAIR▾
Peers100
S&P25
P/S?6.04FAIR▾
Peers100
S&P22
P/FCF?27.7FAIR▾
Peers100
S&P33
EV/EBITDA?46.8HIGH▾
Peers100
S&P3
EV/Sales?5.89FAIR▾
Peers100
S&P29
Returns & Efficiency
ROE?12.1%STRONG▾
Peers50
S&P43
ROA?8.9%STRONG▾
Peers50
S&P70
Cash Flow & Enterprise
FCF?$164.2M
Enterprise Value?$4.4B
Fundamentals ratios updated end of day